Batu Biologics

Batu Biologics is an immuno-oncology company focused on the development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. The company has recently launched an equity crowdfunding campaign seeking investment from accredited investors to bring our tumor angiogenesis targeting immune therapy into the clinic in the United States. Please watch the video below to learn more about our approach to treating and potentially curing cancer.